Lexington, MA Newmark Knight Frank (NKF) completed a 14,764 s/f lease to KabaFusion at 80 Hayden Ave. on behalf of the property owner, Marwick Associates.
80 Hayden Ave. is a 43,208 s/f, three-story office building. The most recent lease completed at 80 Hayden Ave. was signed by KabaFusion to serve as a new eastern headquarters location for the firm. Founded in 2010, KabaFusion is a patient-focused, pharmacist-owned home infusion company specializing in IVIG, SCIG and acute therapies. The company is relocating its east headquarters from 318 Bear Hill Rd. in Waltham, where it leased 3,500 s/f.
NKF executive managing director Mark Roth, managing director Matt Malatesta, director Brendan Daly and associate Brianna Piacitelli represented ownership in the lease negotiations. Jack Whelan and Michael O’Leary of Cushman & Wakefield represented KabaFusion.
“We are pleased to have represented Marwick Associates in this lease transaction,” said Roth. “KabaFusion is a great addition to the large life science cluster at Rte. 2 and I-95. This life science cluster, on the Lexington and Waltham border, now has over two million square feet occupied by companies such as Takeda Pharmaceuticals, Concert Pharmaceuticals, ElevateBio, and Dicerna Pharmaceuticals.”